This is an automatically translated article.
Rucaparib is indicated for the maintenance treatment of patients with ovarian cancer, fallopian tube cancer, primary peritoneal cancer and some other diseases. The drug Rucaparib used is quite complicated, so to be effective in treating patients, it is necessary to know the information about Rucaparib.1. Indications for the use of Rucaparib
Rucaparib is indicated for the maintenance treatment of patients with ovarian cancer, fallopian tube cancer or primary peritoneal cancer that has recurred. Rucaparib is used in patients who have been treated in whole or in part with platinum-based cancer drugs and in patients who have received two or more cancer drugs. Rucaparib is effective in patients with certain types of abnormal BRCA genes that are inherited or may be acquired.
The drug is also indicated in the treatment of metastatic and castration-resistant prostate cancer. Or the case where the patient has certain types of abnormal BRCA genes that are inherited or may be acquired.
2. Dosage of drug Rucaparib
The dose of Rucaparib drug can be different, depending on the doctor's prescription. In addition, the amount of drug used depends on the strength of the drug, the time used between doses ...
For Rucaparib in tablet form, used in the treatment of advanced ovarian cancer, cancer Fallopian tube cancer, primary peritoneal cancer or prostate cancer usually use a dose of 600mg corresponding to 2 tablets of 300mg strength and used twice daily. The time between the first and the next dose should be 12 hours apart. The treating doctor can adjust the dose and duration of use depending on the level of need and tolerance of the patient's body.
Note: The above recommended therapeutic dose for Rucaparib is for reference only. Therefore, before using Rucaparib, patients need to be prescribed by a doctor.
If the patient has missed a dose of Rucaparib, use the missed dose as soon as you remember. However, if there is a gap between the missed dose of Rucaparib and the next dose, it is possible to skip the missed dose and take the next dose. Patients should also note that it is not recommended to double the dose of Rucaparib, because it can cause drug overdose and unwanted side effects that affect the patient's current health during treatment with Rucaparib. Rucaparib drug.
In case the patient accidentally takes an overdose of Rucaparib than prescribed and has some signs of unwanted side effects, it is necessary to take the patient to an emergency at the nearest medical facility to receive treatment. timely medical assistance.
3. Unwanted side effects of the drug Rucaparib
Rucaparib medicine can cause some unwanted side effects depending on the level of response to the patient.
Common side effects may include: bleeding gums, bloating, facial swelling, blood in urine, chills, cough, trouble breathing, loss of voice, stuffy nose, sores, unusual bruising often. ...
Uncommon reactions such as: nausea, vomiting, rash, mouth ulcers or inflammation of the oral mucosa, constipation...
Some notes when using Rucaparib medicine
Rucaparib medicine can make changes in blood activity indicators including increased creatinine related to kidney function or ALT related to liver function, cholesterol. These changes are often a sign of liver and kidney damage. Furthermore, changes in these parameters mean that the performance of the tests may affect the results. Rucaparib may make your skin more sensitive to the sun. That can cause a serious sunburn or burn you. Sun sensitivity can persist and continue even after chemotherapy treatment. The drug can cause birth defects in the fetus, so women who are pregnant or planning to become pregnant should not use Rucaparib. The information about the drug Rucaparib cannot replace the advice of a doctor, so patients should consult a qualified person for appropriate indications.
Please dial HOTLINE for more information or register for an appointment HERE. Download MyVinmec app to make appointments faster and to manage your bookings easily.
